Home LiteratureArticle Details
PMID: 19940258 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

Huppert J, Closhen D, Croxford A, White R, Kulig P, Pietrowski E, Bechmann I, Becher B, Luhmann HJ, Waisman A, Kuhlmann CR

Abstract

Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., Kuhlmann, C. R. W. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

MeSH Terms
Animals Antibodies, Neutralizing/immunology,pharmacology Azepines/pharmacology Blood-Brain Barrier/immunology,metabolism,pathology Cell Line, Transformed Down-Regulation/drug effects,immunology Encephalomyelitis, Autoimmune, Experimental/immunology,metabolism,pathology Endothelial Cells/immunology,metabolism,pathology Enzyme Inhibitors/pharmacology Interleukin-17/antagonists & inhibitors,immunology,metabolism,pharmacology Membrane Proteins/immunology,metabolism Mice Mice, Inbred BALB C Myosin-Light-Chain Kinase NADPH Oxidases/immunology,metabolism Naphthalenes/pharmacology Occludin Oxidative Stress/drug effects,immunology Reactive Oxygen Species/immunology,metabolism T-Lymphocytes, Helper-Inducer/immunology,metabolism,pathology Xanthine Oxidase/immunology,metabolism
Chemicals
Antibodies, Neutralizing Azepines Enzyme Inhibitors Il17a protein, mouse Interleukin-17 Membrane Proteins Naphthalenes Occludin Ocln protein, mouse Reactive Oxygen Species ML 7 Xanthine Oxidase NADPH Oxidases Myosin-Light-Chain Kinase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Huppert Jula
University Medical Center of the Johannes Gutenberg University Mainz, Institute of Physiology and Pathophysiology, Duesbergweg 6, 55131 Mainz, Germany.
Closhen Dorothea
Croxford Andrew
White Robin
Kulig Paulina
Pietrowski Eweline
Bechmann Ingo
Becher Burkhard
Luhmann Heiko J
Waisman Ari
Kuhlmann Christoph R W
Article Info
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Abbr.
FASEB J
ISSN
1530-6860
Published
2010-04-00
Epub
2009-00-25
Pages
1023-34
Language
English
Region
United States
NLM ID
8804484
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com